Skip to main content
Home

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges
  • Open Education

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges
  • Open Education

Helen McShane: Women in science

Series
Career Equality Talks
Video Audio Embed
A career in juggling, organisation and guilt management
Professor Helen McShane has been working on a new TB vaccine for 10 years. There are about 9 million new cases and 1.7 million deaths every year from tuberculosis. She developed MVA85A, a vaccine with the aim to boost the cellular immune response induced by BCG. Developing countries are especially in need of a new vaccine since HIV and TB epidemics overlap and show a devastating synergy.

More in this series

View Series
Career Equality Talks

Bridget Ogilvie: Women in Science

Dame Bridget Ogilvie discusses her life and illustrious scientific career, at The Wellcome Trust Centre for Human Genetics’ Women in Science series
Previous
Career Equality Talks

Prof Xin Lu: Women in Science

Every cloud has a silver lining: optimisism and persistence
Next
Licence
Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/

Episode Information

Series
Career Equality Talks
People
Helen McShane
Keywords
helen mcshane
women in science
tuberculosis
Department: Nuffield Department of Clinical Medicine
Date Added: 10/12/2014
Duration: 00:23:03

Subscribe

Apple Podcast Video Apple Podcast Audio Audio RSS Feed Video RSS Feed

Download

Download Video Download Audio

Footer

  • About
  • Accessibility
  • Contribute
  • Copyright
  • Contact
  • Privacy
'Oxford Podcasts' Twitter Account @oxfordpodcasts | MediaPub Publishing Portal for Oxford Podcast Contributors | Upcoming Talks in Oxford | © 2011-2022 The University of Oxford